# A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

> **NCT01227356** · PHASE2 · COMPLETED · sponsor: **Uppsala University** · enrollment: 112 (actual)

## Conditions studied

- Health Care Quality
- Health Care Evaluation

## Interventions

- **DRUG:** imatinib and pegylated interferon

## Key facts

- **NCT ID:** NCT01227356
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2009-03
- **Final completion:** 2009-11
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2010-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227356, "A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01227356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*